Rubric Capital Management (New York)’s Innate Pharma IPHA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-250,000
Closed -$960K 74
2020
Q3
$960K Sell
250,000
-681,673
-73% -$3.87M 0.09% 61
2020
Q2
$6.38M Hold
931,673
0.74% 40
2020
Q1
$6.22M Sell
931,673
-418,327
-31% -$2.82M 1.02% 34
2019
Q4
$8.69M Buy
+1,350,000
New +$8.3M 1.01% 33

Other funds holding IPHA